Comparison of the HAS‐BLED versus ORBIT scores in predicting major bleeding among Asians receiving direct‐acting oral anticoagulants

Phannita Wattanaruengchai; Surakit Nathisuwan; Khemajira Karaketklang; Wanwarang Wongcharoen; Arintaya Phrommintikul; Professor Gregory Lip

doi:10.1111/bcp.15145

Related publications

Article2023

Comparative validation of HAS‐BLED, GARFIELD‐AF and ORBIT bleeding risk scores in Asian people with atrial fibrillation treated with oral anticoagulant: A report from the COOL‐AF registry

Ply Chichareon, Arjbordin Winijkul, Professor Gregory Lip, Rungroj Krittayaphong

Article2021

Comparison of the HAS-BLED, ORBIT and ATRIA bleeding risk scores in 399,344 patients with atrial fibrillation and cancer

Daniele Pastori, A Marang, Arnaud Bisson, Julien Herbert, Professor Gregory Lip, Laurent Fauchier

Article2018

Predicting Bleeding Events in Anticoagulated Patients With Atrial Fibrillation: A Comparison Between the HAS‐BLED and GARFIELD‐AF Bleeding Scores

Marco Proietti, José Miguel Rivera‐Caravaca, María Asunción Esteve‐Pastor, Giulio Francesco Romiti, Francisco Marı́n, Professor Gregory Lip

Article2016

Major Bleeding in Patients with Non-Valvular Atrial Fibrillation: Impact of Time in Therapeutic Range on Contemporary Bleeding Risk Scores

Marco Proietti, Keitaro Senoo, Deirdre A. Lane, Professor Gregory Lip

Article2022

Predicting performance of the HAS-BLED and ORBIT bleeding risk scores in patients with atrial fibrillation treated with Rivaroxaban: Observations from the prospective EMIR Registry

María Asunción Esteve‐Pastor, José Miguel Rivera‐Caravaca, Vanessa Roldán, Marcelo Sanmartı́n, Fernando Arribas, Jaime Masjuán, Vivencio Barrios, Juan Cosı́n-Sales, Román Freixa‐Pamias, Esther Recalde, Alejandro Pérez Cabeza, José Manuel Vázquez‐Rodríguez, Carles Ràfols, Manuel Anguita Sánchez, Professor Gregory Lip, Francisco Marı́n